Matches in Wikidata for { <http://www.wikidata.org/entity/Q93329006> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q93329006 description "clinical trial" @default.
- Q93329006 description "ensayo clínico" @default.
- Q93329006 description "ensayu clínicu" @default.
- Q93329006 description "klinisch onderzoek" @default.
- Q93329006 description "клінічне випробування" @default.
- Q93329006 description "临床试验" @default.
- Q93329006 name "PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds" @default.
- Q93329006 name "PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds" @default.
- Q93329006 type Item @default.
- Q93329006 label "PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds" @default.
- Q93329006 label "PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds" @default.
- Q93329006 prefLabel "PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds" @default.
- Q93329006 prefLabel "PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds" @default.
- Q93329006 P1132 Q93329006-C70D7918-91EE-498E-91A8-1C2CC68DE17C @default.
- Q93329006 P1476 Q93329006-2829BD23-7368-4CB6-A5BB-731FBED3B541 @default.
- Q93329006 P17 Q93329006-64C5ED38-2D3E-4355-A1AA-B8A03CA07CE0 @default.
- Q93329006 P1813 Q93329006-F8F1A1ED-A70D-46CC-8E16-B19506D2E9D5 @default.
- Q93329006 P2899 Q93329006-88C7D291-BA2B-4D8A-8673-525ED18051BA @default.
- Q93329006 P3098 Q93329006-E706ECDA-46A3-4A31-BA91-D64CB47D0B95 @default.
- Q93329006 P31 Q93329006-E19C5037-235A-4A4C-9809-9DDE60E4E6EE @default.
- Q93329006 P4135 Q93329006-67FD853E-E126-46BA-B1FA-DEF3D5BCBE66 @default.
- Q93329006 P4844 Q93329006-5539324F-F7E4-4DB5-BB89-07763E257D2D @default.
- Q93329006 P4844 Q93329006-C2A39ABC-A316-4104-A970-7886881075FD @default.
- Q93329006 P580 Q93329006-2B7EC082-8D60-4BA8-9F4B-6F3A5FE3B937 @default.
- Q93329006 P582 Q93329006-9DB09B30-F095-4EF3-872D-B4BCEE1E43A1 @default.
- Q93329006 P6099 Q93329006-3837CCD2-AC9A-445B-AE1A-90839304BCB3 @default.
- Q93329006 P8005 Q93329006-CDD28F5C-83F0-471D-87DA-00EA4BB56934 @default.
- Q93329006 P8363 Q93329006-FBE5E716-E36D-4FB9-9DDF-026752F45F1C @default.
- Q93329006 P1132 "+400" @default.
- Q93329006 P1476 "Use and Dosage of Hydroxychloroquine and Chloroquine to Convert Symptomatic RT-PCR Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Infectious Disease 2019 (COVID-19) Patients to RT- PCR-Negative as a Means to Reduce Hospitalization Rate" @default.
- Q93329006 P17 Q843 @default.
- Q93329006 P1813 "PRECISE" @default.
- Q93329006 P2899 "+20" @default.
- Q93329006 P3098 "NCT04351191" @default.
- Q93329006 P31 Q30612 @default.
- Q93329006 P4135 "+50" @default.
- Q93329006 P4844 Q421094 @default.
- Q93329006 P4844 Q422438 @default.
- Q93329006 P580 "2020-04-15T00:00:00Z" @default.
- Q93329006 P582 "2020-05-30T00:00:00Z" @default.
- Q93329006 P6099 Q42825046 @default.
- Q93329006 P8005 Q76649708 @default.
- Q93329006 P8363 Q78089383 @default.